FDA, Markets
FDA Delays KalVista Drug Review for HAE
50% center coverage3 sources
FDA
First 100 Days
See how you scored in predicting Trump's first 100 days
Latest News
FDA, Markets
CERo Therapeutics Gains FDA Orphan Drug Designation for Leukemia Treatment
50% center coverage2 sources
FDA, Markets
CERo Therapeutics Gains FDA Orphan Drug Designation for Leukemia Treatment
50% center coverage2 sources
FDA
Dyne Therapeutics Receives FDA Breakthrough Designation for DM1 Treatment
100% left coverage1 source
FDA
Dyne Therapeutics Receives FDA Breakthrough Designation for DM1 Treatment
100% left coverage1 source
FDA
FDA Accepts Aquestive New Drug Application for Oral Epinephrine
100% left coverage1 source
FDA
FDA Accepts Aquestive New Drug Application for Oral Epinephrine
100% left coverage1 source
FDA, Markets
FDA Clears Amended Ocugen Trial for Stargardt Disease
50% center coverage2 sources
FDA, Markets
FDA Clears Amended Ocugen Trial for Stargardt Disease
50% center coverage2 sources
FDA
FDA Approves Pembrolizumab for Resectable Locally Advanced Head Neck Cancer
100% left coverage1 source
FDA
FDA Approves Pembrolizumab for Resectable Locally Advanced Head Neck Cancer
100% left coverage1 source
FDA
FDA Approves First Lab-Grown Salmon for US Commercial Sale
50% left coverage2 sources
FDA
FDA Approves First Lab-Grown Salmon for US Commercial Sale
50% left coverage2 sources
FDA, Heroin
FDA Renews Warning on Tianeptine Gas Station Supplements
100% left coverage2 sources
FDA, Heroin
FDA Renews Warning on Tianeptine Gas Station Supplements
100% left coverage2 sources
First 100 Days
See how you scored in predicting Trump's first 100 days
Most Reported By
News from FDA
News from FDA